Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

The Effects of the Alkaloid Tambjamine J on Mice Implanted with Sarcoma 180 Tumor Cells

Loading...
Thumbnail Image

Date

Authors

Barros-Nepomuceno, Francisco Washington
Viana, Daniel de Araujo
Pinheiro, Daniel Pascoalino
de Oliveira, Fatima de Cassia Evangelista
Ferreira, Jamile Magalhaes
de Queiroz, Maria Goretti
Ma, Xing
Cavalcanti, Bruno Coelho
Pessoa, Claudia
Banwell, Martin

Journal Title

Journal ISSN

Volume Title

Publisher

Wiley

Abstract

The tambjamines are a small group of bipyrrolic alkaloids that, collectively, display a significant range of biological activities including antitumor, antimicrobial and immunosuppressive properties. The key objective of the present study was to undertake preclinical assessments of tambjamine J (T‐J) so as to determine its in vivo antitumor effects. To that end, sarcoma 180 cells were transplanted in mice and the impacts of the title compound then evaluated using a range of protocols including hematological, biochemical, histopathological, genotoxic and clastogenic assays. As a result it was established that this alkaloid has a significant therapeutic window and effectively reduces tumor growth (by 40 % and 79 % at doses of 10 and 20 mg/kg/day, respectively). In this regard it displays similar antitumor activity to the anticancer agent cyclophosphamide and alters animal weight in an analogous manner.

Description

Keywords

Citation

Source

ChemMedChem

Book Title

Entity type

Access Statement

License Rights

Restricted until

2099-12-31